By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Mosaic's Q2 results show margin erosion due to higher raw material costs and lower volumes, with phosphate segment losses widening significantly. The company's response includes a modest capex cut and maintained production guidance, suggesting caution but not panic. However, the real concern is the potential impact of further Brazilian real weakness on Fertilizantes margins and the risk of negative cash flow leading to a debt-to-EBITDA increase and potential credit rating downgrade.
Risk: Further weakness in the Brazilian real leading to amplified volume shortfalls and another earnings miss.
Opportunity: A rebound in global fertilizer demand and normalization of sulfur costs, assuming the Brazilian real recovers.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
(RTTNews) - The Mosaic Co. (MOS) on Tuesday posted a second-quarter net loss, as higher raw material costs and lower sales volumes offset stronger phosphate and potash prices.
The fertilizer producer posted a net loss attributable to Mosaic of $272.8 million, or $0.86 per share, compared with net income of $410.7 million, or $1.29 per share, in the prior-year quarter.
Adjusted earnings were $0.13 per share, compared to $0.51 per share last year.
Net sales declined to $2.82 billion from $3.01 billion a year earlier.
The Phosphate segment reported an operating loss of $104 million, compared with a loss of $8 million a year ago, as higher raw material costs and lower production volumes more than offset higher selling prices. Potash operating earnings were $195 million, essentially flat from $194 million last year, while Mosaic Fertilizantes swung to an operating loss of $41 million from earnings of $109 million due to lower sales volumes and higher sulfur costs.
Looking ahead, Mosaic reduced its 2026 capital expenditure outlook to $1.2 billion from the previously expected $1.25 billion. The company continues to expect potash production of about 9 million tonnes this year.
For the third quarter, it forecasts phosphate sales volumes of 1.1 million to 1.4 million tonnes and potash sales volumes of 2.0 million to 2.2 million tonnes.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Persistent cost inflation and volume softness have overwhelmed price tailwinds, making Mosaic's earnings recovery uncertain and the stock vulnerable to further multiple compression."
Mosaic's Q2 swing to a $272.8M net loss, with adjusted EPS collapsing from $0.51 to $0.13 and sales down 6% to $2.82B, confirms margin compression from surging raw material (sulfur, ammonia) and production costs that outran realized phosphate and potash prices. Phosphate swung deeper into the red, while Mosaic Fertilizantes flipped from +$109M to -$41M operating profit on volume weakness. The modest capex cut to $1.2B and maintained 9Mt potash guidance signal caution. At 11.2x forward P/E the stock looks optically cheap, but only if nutrient prices stabilize and volumes rebound in H2; otherwise further downside is probable.
The strongest case against immediate bearishness is that fertilizer prices remain structurally elevated versus historical averages due to tight global supply and sustained ag demand; if Q3 volumes hit the high end of guidance (1.4Mt phosphate, 2.2Mt potash) and input costs peak, Mosaic could deliver a sharp earnings rebound that re-rates the multiple toward 15x.
"Mosaic's inability to pass through rising input costs to customers indicates a structural erosion of their competitive moat in the current commodity cycle."
Mosaic’s Q2 results are a classic margin-squeeze play. While the market focuses on the $0.86 per share loss, the real story is the operational inefficiency in the Phosphate segment, which saw losses widen thirteen-fold year-over-year. Management’s decision to trim Capex to $1.2 billion for 2026 is a defensive signal, suggesting they are prioritizing cash preservation over growth as sulfur and raw material costs bite. With sales volume contracting, Mosaic is losing its pricing power leverage. Unless they can stabilize input costs, the stock will likely trade sideways to lower, trapped by the volatility of global fertilizer demand and rising production overheads.
If global grain stocks remain tight, farmers will be forced to pay whatever price Mosaic dictates, potentially leading to a massive margin expansion in Q3/Q4 that the current bearish sentiment ignores.
"MOS's loss stems from input costs outpacing output prices, indicating either temporary margin compression or permanent loss of cost competitiveness—the guidance will tell us which."
MOS's Q2 collapse—$272.8M loss vs. $410.7M profit YoY—looks catastrophic on the surface, but the phosphate segment's $104M operating loss despite higher prices signals a structural cost problem, not cyclical weakness. Raw material inflation (sulfur, ammonia) is outpacing pricing power. However, Potash held flat at $195M earnings despite volume/price headwinds, suggesting that segment has genuine pricing leverage. The real question: is this a temporary margin squeeze as input costs normalize, or evidence that MOS's cost structure is permanently uncompetitive? The modest capex cut ($50M) and maintained production guidance suggest management isn't panicking—yet.
If fertilizer demand is actually rolling over (not just MOS's execution), lower Q3 volume guidance (1.1–1.4M phosphate tonnes) could be the canary. A demand recession would make cost-cutting irrelevant and turn this into a multi-quarter earnings grind.
"Near-term downside risk persists from volume and cost pressures, but price strength in phosphate/potash could support a rebound if demand holds and costs normalize."
Q2 shows margin erosion from higher raw material costs and lower volumes, even as some segments benefit from higher selling prices. A net loss and lower adjusted EPS signal near-term pressure, but flat potash earnings and a modest capex cut suggest Mosaic is prioritizing cash preservation and cost discipline. The real swing factor is Fertilizantes volumes and sulfur-cost exposure; if those normalize and global fertilizer demand remains resilient, a rebound is plausible. The Q3 guidance implies continued volatility, and the capex trim hints at a cautious stance rather than growth.
But the weakness could be transitory if seasonality or macro demand improves, and sulfur costs stabilize; if so, Mosaic might surprise to the upside even from a weak quarter.
"FX exposure in Brazil, not just raw materials, is the bigger unmentioned driver of sustained margin pressure."
Claude's structural-cost thesis misses that Mosaic's phosphate losses stem more from Brazilian real weakness crushing Fertilizantes margins than permanent uncompetitiveness. The $50M capex trim is trivial versus the $1.2B total; real risk nobody flagged is further FX volatility amplifying Q3 volume shortfalls. If BRL doesn't recover, even normalized sulfur costs won't prevent another earnings miss.
"Mosaic's mounting debt-to-EBITDA ratio and potential for a credit downgrade pose a greater risk to the stock than mere FX volatility or input cost fluctuations."
Grok, you’re right about the BRL, but you’re ignoring the balance sheet risk. Mosaic’s debt-to-EBITDA is creeping up as cash flow turns negative. If they don't slash capex further, they risk a credit rating downgrade, which would spike interest expenses just as earnings trough. Claude, the 'structural cost' argument is flawed because these are commodity inputs, not internal inefficiencies. The real danger is a sustained inventory destocking cycle in Brazil that renders all volume guidance optimistic.
"FX volatility in Brazil compounds input-cost pressure more than global commodity normalization can offset in Q3."
Gemini's debt-to-EBITDA concern is real, but the inventory destocking thesis needs precision. Brazil's fertilizer destocking is cyclical—tied to farmer cash flow post-harvest, not structural demand collapse. The BRL weakness Grok flagged is the actual amplifier: if real weakens further, Fertilizantes' dollar-denominated costs spike while local pricing lags, crushing margins independent of global sulfur normalization. That's the second-order effect nobody quantified.
"The bigger unseen risk is Mosaic’s liquidity and covenant pressure, not just debt-to-EBITDA, which could force sharper capex cuts or asset sales and reprice the stock before any Q3 rebound."
Gemini’s debt-to-EBITDA concern is valid, but the bigger unseen risk is Mosaic’s liquidity ladder. Negative FCF and rising leverage tighten covenants; without meaningful cash preservation, they may need sharper capex cuts or asset sales just to keep doors open, which would cap upside. If refinancing costs spike or a covenant breach looms, the stock could re-price well before any Q3 rebound, regardless of near-term price relief.
Mosaic's Q2 results show margin erosion due to higher raw material costs and lower volumes, with phosphate segment losses widening significantly. The company's response includes a modest capex cut and maintained production guidance, suggesting caution but not panic. However, the real concern is the potential impact of further Brazilian real weakness on Fertilizantes margins and the risk of negative cash flow leading to a debt-to-EBITDA increase and potential credit rating downgrade.
A rebound in global fertilizer demand and normalization of sulfur costs, assuming the Brazilian real recovers.
Further weakness in the Brazilian real leading to amplified volume shortfalls and another earnings miss.